ReviewMolecular genetics and genomics : MGG2026
Circular RNAs: key regulators in cancer stem cell dynamics.
Review in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Functions and mechanisms of circular RNAs in cancer stem cells and therapy resistance.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Circular RNAs (circRNAs) are non-coding RNAs with single stranded structure devoid of a 5’ cap and poly-A tail. Although the first circRNA was discovered in the 1970s, the abundance and significance of circRNAs was only realized with the advent of high-throughput RNA-sequencing technologies and bioinformatics analysis. The recent studies have highlighted the variable expression of circRNAs in patient tumor samples. Cancer stem cells (CSCs) are thought to be responsible for initiation and progression of tumors. The cancer stem cell hypothesis states that a small subpopulation of cells within the tumor possesses the ability to self-renew and differentiate into non-stem cells of the tumor. CSCs have the characteristic features of chemo- and radio-resistance, the ability to metastasize, and are often linked with cancer relapse. The clinical data indicates a negative correlation between the proportion of CSCs in tumors and the overall survival of cancer patients. The higher the number of CSCs in a tumor sample, the more aggressive is the tumor. Targeting CSCs is, therefore, a potent therapeutic approach in cancer treatment. This review provides a comprehensive overview of circRNAs and critically evaluates their role in the regulation of CSCs.
Indexed as
Identifiers
41632314What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.